Preview

Modern Rheumatology Journal

Advanced search

Joint involvement in Lö fgren's syndrome

https://doi.org/10.14412/1996-7012-2016-3-35-40

Abstract

Objective: to study the clinical, laboratory, and instrumental features of joint involvement in patients with Löfgren's syndrome.

Patients and methods. Examinations were made in 125 patients, among whom there were 21 men and 104 women (male:female ratio, 1:5); mean age, 42±12 years (from 18 to 69 years), the referral diagnoses were erythema nodosum (EN), panniculitis or vasculitis.

Results. All the patients complained of painful red indurations on the upper and lower extremities; there were also complaints of joint pain (83%), cough, weakness, hyperhidrosis, dyspnea, myalgia, and sore throat (55%), and subfebrile temperatures (50%). Arthralgias were noted in all the cases; 70% had arthritis that was observed manly in the ankle joints (62%). In all the patients, joint damage was concurrent with EN. Articular manifestations preceded EN in 35 (28%) patients. Laboratory tests showed that the median erythrocyte sedimentation rate was 20 [14; 31] mm/hr and C-reactive protein (CRP) was 10 [6; 21] mg/l. Elevated CRP levels were significantly more common in arthritis (p = 0.003) and nodular fusion (p=0.04) and directly related to the number of subcutaneous nodules (p=0.008; r=0.29). Chest computed tomography revealed intrathoracic lymphadenopathy in all the patients; ground glass lung tissue injury (Stage II) was identified in 42% of cases. Joint damage did not depend on the X-ray stage of sarcoidosis. 54% of the patients took nonsteroidal anti-inflammatory drugs, 60% received hydroxychloroquine 600 mg/day, and 50% had glucocorticoids (GC) 4–6 mg/day. 35% of the patients received combined therapy with GC and cyclophosphamide 200 mg/week or methotrexate 15 mg/week. Articular syndrome virtually completely regressed during a year. Arthralgias in the ankle persisted in a few (4%) cases.

About the Authors

O. N. Egorova
V.A. Nasonova Research Institute of Rheumatology, Moscow, Russia 34A, Kashirskoe Shosse, Moscow 115522
Russian Federation


Yu. A. Karpova
V.A. Nasonova Research Institute of Rheumatology, Moscow, Russia 34A, Kashirskoe Shosse, Moscow 115522
Russian Federation


N. M. Savushkina
V.A. Nasonova Research Institute of Rheumatology, Moscow, Russia 34A, Kashirskoe Shosse, Moscow 115522
Russian Federation


B. S. Belov
V.A. Nasonova Research Institute of Rheumatology, Moscow, Russia 34A, Kashirskoe Shosse, Moscow 115522
Russian Federation


References

1. Визель АА, редактор. Саркоидоз: от гипотезы к практике. Казань: Фэн; 2004. С. 18-79. [Vizel' AA, editor. Sarkoidoz: ot gipotezy k praktike [Sarcoidosis: from hypothesis to practice]. Kazan': Fen; 2004. P. 18-79.].

2. Gedalia A, Khan TA, Shetty AK, et al. Childhood sarcoidosis: Louisiana experience. Clin Rheumatol. 2016 Jul;35(7):1879-84. doi: 10.1007/s10067-015-2870-9. Epub 2015 Jan 24.

3. Чучалин АГ, Авдеев СН, Баранова ОЛ и др. Диагностика и лечение саркоидоза (Федеральные согласительные клинические рекомендации). 2014. [Chuchalin AG, Avdeev SN, Baranova OL, et al. Diagnosis and treatment of sarcoidosis (Federal conciliation guidelines).2014]. www.pulmonology.ru/publications/guide.php.

4. Kobak S. Sarcoidosis: a rheumatologist's perspective. Ther Adv Musculoskelet Dis. 2015 Oct;7(5):196-205. doi: 10.1177/ 1759720X15591310.

5. Visser H, Vos K, Zanelli E, et al. Sarcoid arthritis: clinical characteristics, diagnostic aspects, and risk factors. Ann Rheum Dis. 2002 Jun;61(6):499-504.

6. Lindsley CB, Petty RE. Overview and report on international registry of sarcoid arthritis in childhood. Curr Rheumatol Rep. 2000 Aug;2(4):343-8.

7. Resnick D, Niwayama G. Sarcoidosis. In: Resnick D, Niwayama G, editors. Diagnosis of bone and joint disorders. 3rd ed. Philadelphia, Pa: Saunders; 1995. P. 4333-52.

8. Егорова ОН, Белов БС, Раденска-Лоповок СГ и др. К проблеме дифференциальной диагностики панникулитов. Врач. 2014;(11):14-9. [Egorova ON, Belov BS, Radenska- Lopovok SG, et al. To the problem of differential diagnosis of panniculitis. Vrach. 2014;(11):14-9. (In Russ.)].

9. Kirresh O, Schofield J, George G. Acute sarcoidosis: Lö fgren's syndrome. Br J Hosp Med (Lond). 2015 Mar;76(3):154-8. doi: 10.12968/hmed.2015.76.3.154.

10. Mana J, Gomez-Vaquero C, Montero A, et al. Lö fgren's syndrome revisited: a study of 186 patients. Am J Med. 1999 Sep;107(3):240-5.

11. Grunewald J, Eklund A. Sex-specific manifestations of Lö fgren's syndrome. Am J Respir Crit Care Med. 2007 Jan 1;175(1):40-4. Epub 2006 Oct 5.

12. Pettersson T. Sarcoid and erythema nodosum arthropathies. Baillieres Best Pract Res Clin Rheumatol. 2000 Sep;14(3):461-76.

13. Judson MA. Advances in the diagnosis and treatment of sarcoidosis. F1000Prime Rep. 2014 Oct 1;6:89. doi: 10.12703/P6-89. eCollection 2014.

14. Govender P, Berman JS. The Diagnosis of Sarcoidosis. Clin Chest Med. 2015 Dec;36(4):585-602. doi: 10.1016/j.ccm. 2015.08.003. Epub 2015 Oct 9.


Review

For citations:


Egorova ON, Karpova YA, Savushkina NM, Belov BS. Joint involvement in Lö fgren's syndrome. Sovremennaya Revmatologiya=Modern Rheumatology Journal. 2016;10(3):35-40. (In Russ.) https://doi.org/10.14412/1996-7012-2016-3-35-40

Views: 1998


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1996-7012 (Print)
ISSN 2310-158X (Online)